Literature DB >> 8051275

Effective use of frozen donor peripheral blood mononuclear cells for human immunodeficiency virus type 1 isolation from vertically infected pediatric patients.

M O Paul1, S Tetali, S Pahwa.   

Abstract

In this study, we examined variables related to human immunodeficiency virus (HIV) isolation utilizing samples from 51 HIV-infected (153 plasma and 122 peripheral blood mononuclear cell [PBMC] samples) and 57 uninfected (182 plasma and 163 PBMC samples) infants. Our chief observation was that cryopreservation of donor PBMCs does not significantly alter their sensitivity or specificity for isolation of HIV from patient PBMCs or plasma.

Entities:  

Mesh:

Year:  1994        PMID: 8051275      PMCID: PMC263709          DOI: 10.1128/jcm.32.5.1379-1382.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children.

Authors:  G Scarlatti; V Lombardi; A Plebani; N Principi; C Vegni; G Ferraris; A Bucceri; E M Fenyö; H Wigzell; P Rossi
Journal:  AIDS       Date:  1991-10       Impact factor: 4.177

2.  Enumeration of antigen sites on cells by flow cytometry.

Authors:  C D Dawson; J A Scheppler; J K Nicholson; R C Holman
Journal:  Pathobiology       Date:  1991       Impact factor: 4.342

Review 3.  Advances and problems in the diagnosis of human immunodeficiency virus infection in infants.

Authors:  M F Rogers; C Y Ou; B Kilbourne; G Schochetman
Journal:  Pediatr Infect Dis J       Date:  1991-07       Impact factor: 2.129

4.  Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection.

Authors:  A De Rossi; A E Ades; F Mammano; A Del Mistro; A Amadori; C Giaquinto; L Chieco-Bianchi
Journal:  AIDS       Date:  1991-01       Impact factor: 4.177

5.  A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1.

Authors:  C Hutto; W P Parks; S H Lai; M T Mastrucci; C Mitchell; J Munoz; E Trapido; I M Master; G B Scott
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

6.  Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.

Authors:  F B Hollinger; J W Bremer; L E Myers; J W Gold; L McQuay
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

7.  Isolation of HIV-1 from plasma of infected individuals: an analysis of experimental conditions affecting successful virus propagation.

Authors:  R L Dewar; M D Sarmiento; E S Lawton; H M Clark; P E Kennedy; A Shah; M Baseler; J A Metcalf; H C Lane; N P Salzman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  HIV replication during the first weeks of life.

Authors:  A Krivine; G Firtion; L Cao; C Francoual; R Henrion; P Lebon
Journal:  Lancet       Date:  1992-05-16       Impact factor: 79.321

9.  Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques.

Authors:  W Borkowsky; K Krasinski; H Pollack; W Hoover; A Kaul; T Ilmet-Moore
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays.

Authors:  A M Comeau; J A Harris; K McIntosh; B J Weiblen; R Hoff; G F Grady
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  1 in total

1.  Diagnosis of human immunodeficiency virus type 1 infection in infants by immune complex dissociation p24 assay.

Authors:  M O Paul; G Toedter; D Hofheinz; S Tetali; S Pelton; M Marecki; A Brena; E J Abrams; S Landesman; S Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  1997-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.